Peter Köllensperger

Direktør NTNU NanoLab & Førsteamanuensis II ved Institutt for klinisk og molekylær medisin Institutt for klinisk og molekylær medisin Fakultet for naturvitenskap
73591490

Bakgrunn og aktiviteter

I work at the NTNU NanoLab as process group leader, and as Director during Kay Gastingers absence. The NanoLab is a 700 sqm cleanroom facility offering state-of-the-art nano- and microfabrication and characterisation equipment as well as areas for chemical synthesis and biological work. As part of NorFab, the Norwegian infrastructure for micro- and nanofabrication, we provide access for Norwegian researchers independent of their academic, institute or company affiliation.  A non-exhaustive list of equipment available in our cleanrooms can be accessed by clicking the NanoLab link on the right.

In addition, I am responsible for the Nanomedicine I (MOL3014) course at the Department of Clinical and Molecular Medicine during Prof. Halaas' sabbatical.

I studied biochemistry/biotechnology as an undergraduate, and have a PhD in biomedical engineering (Prof. Tony Cass’ group), both from Imperial College London, where I also held a Royal Academy of Engineering Enterprise Fellowship, and worked in the cleanrooms of the Optical and Semiconductor Devices group (with Prof. Mino Green) and the London Centre for Nanotechnology (UCL). In 2014, I joined the Bionanotechnology group at NTNU (Prof. Pawel Sikorski) through a Marie Curie Fellowship.

My overarching research interest lies in making biosensing / medical technologies more accessible to doctors and the general public through the use of nanotechnology.

Prior to returning to academia, I worked as a senior analyst in the Healthcare Investment Banking group at Jefferies International, advising pharma, biotech and medtech firms on mergers, acquisitions and corporate finance.